Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
29.76
-0.52 (-1.72%)
Nov 16, 2026, 4:00 PM EST - Market closed

Avalyn Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
145.4252.3223.96
Short-Term Investments
182.0386.0986.68
Cash & Short-Term Investments
327.46138.41110.63
Cash Growth
-25.11%-
Other Receivables
1.550.540.59
Receivables
1.550.540.59
Prepaid Expenses
1.40.710.31
Other Current Assets
3.33.912.86
Total Current Assets
333.71143.56114.39
Property, Plant & Equipment
3.132.320.09
Long-Term Investments
59.14-7.49
Other Long-Term Assets
3.3232.55
Total Assets
399.3148.88124.52

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
2.73.762.28
Accrued Expenses
9.429.896.47
Current Portion of Leases
0.840.44-
Total Current Liabilities
12.9614.098.74
Long-Term Leases
1.271.23-
Total Liabilities
29.0515.328.74

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Common Stock
0.070.020.01
Additional Paid-In Capital
72226.555.43
Retained Earnings
-350.82-265.36-180.16
Comprehensive Income & Other
-0.990.130.2
Total Common Equity
370.25-238.66-174.52
Shareholders' Equity
370.25133.57115.78
Total Liabilities & Equity
399.3148.88124.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
16.931.67-
Net Cash (Debt)
369.67136.74118.12
Net Cash Growth
-15.76%-
Net Cash Per Share
19.22140.82437.25
Filing Date Shares Outstanding
44.521.230.28
Total Common Shares Outstanding
44.391.230.28
Working Capital
320.75129.47105.64
Book Value Per Share
8.34-194.47-630.46
Tangible Book Value
370.25-238.66-174.52
Tangible Book Value Per Share
8.34-194.47-630.46
Machinery
0.440.160.11
Construction In Progress
0.070.68-
SEC Filings: 10-K · 10-Q